Brief: Vaxart posts Q1 basic EPS USD -0.19
04/05/2023 22:34
May 4 (Reuters) - Vaxart Q1 basic EPS USD -0.19. * Q1 net income USD -25.14 million * Q1 pretax profit USD -25.111 million * Q1 operating income USD -25.572 million * Q1 operating expenses USD 26.247 million
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts